You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RVMD Exercise Disclosure
Sandler Alan B. · SEC Form 4 · Filed Oct 1, 2026
Exercise
Calculated transaction value
$0
Sandler Alan B. Chief Development Officer
RVMD
Revolution Medicines
RVMD
Transaction date
Sep 29, 2026
Public filing date
Oct 1, 2026
Filing lag
Filed 2 days later
RVMD daily price context
Close on/before transaction
$204.48
Sep 29, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 6,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001835966-26-000008
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$1.63M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Revolution Medicines, Inc. RVMD Current | Exercise | Sep 29, 2026 | $0 |
| Revolution Medicines, Inc. RVMD | Sale | Sep 29, 2026 | $324.57K |
| Revolution Medicines, Inc. RVMD | Sale | Sep 29, 2026 | $202.81K |
| Revolution Medicines, Inc. RVMD | Exercise | Sep 29, 2026 | $353.04K |
| Revolution Medicines, Inc. RVMD | Sale | Sep 29, 2026 | $441.8K |
| Revolution Medicines, Inc. RVMD | Sale | Sep 29, 2026 | $244.48K |
| Revolution Medicines, Inc. RVMD | Sale | Sep 29, 2026 | $61.62K |